Lunit Joins Forces with SEHA for Innovative AI Breast Cancer Screening in UAE

Lunit Partners with SEHA for Advanced AI Breast Cancer Screening

In a significant development for breast cancer detection, Lunit (KRX:328130.KQ), a prominent provider of AI-powered diagnostic solutions, has entered into a multi-year partnership with Abu Dhabi Health Services Company, also known as SEHA. SEHA represents the largest healthcare network in the UAE and plays a crucial role in the nation's public health infrastructure. This collaboration will see Lunit's innovative AI solution, Lunit INSIGHT MMG, implemented across SEHA's vast network, which includes 14 hospitals and over 70 primary healthcare facilities.

Strategic Agreement to Enhance Cancer Screening

The agreement, spanning five years, aims to leverage Lunit INSIGHT MMG to analyze over a hundred thousand mammography images, enhancing the efficiency and accuracy of breast cancer screenings throughout the UAE. The deployment of this advanced technology follows a successful proof-of-concept evaluation conducted by SEHA and Lunit, which began in 2022. The positive outcomes from this evaluation have paved the way for a full-scale rollout, marking a major milestone in AI-driven cancer screening in the Middle East.

Brandon Suh, CEO of Lunit, expressed his enthusiasm for the partnership, stating, "The UAE is a key market in Lunit's global expansion, and we are thrilled to strengthen our collaboration with SEHA. This long-term partnership underscores SEHA's confidence in our AI-driven solutions and our mutual commitment to advancing breast cancer screening and early detection. By utilizing Lunit's state-of-the-art AI technology, SEHA can enhance its radiology workflow, ultimately improving patient outcomes."

SEHA and Lunit: A Promising Collaboration

SEHA, part of PureHealth—the largest integrated healthcare platform in the Middle East—serves as a backbone for medical services in the region, extending from urban centers to remote areas. The initiative to adopt Lunit's AI solution aligns perfectly with SEHA's mission to implement world-class medical technologies and reflects the UAE's ambition to enhance healthcare delivery.

This partnership also aligns with national initiatives aimed at improving early cancer detection rates. The UAE's Ministry of Health and Prevention has long advocated for preventive screenings and timely medical interventions, highlighted through annual breast cancer awareness campaigns.

The Growth of AI in Healthcare

The medical AI market continues to show promising growth in the Middle East. Projections indicate that it will rise from approximately USD 200 million in 2024 to between USD 1–1.5 billion within the next 5 to 7 years. In particular, AI applications within UAE healthcare are expected to reach USD 137.9 million by 2030, driven by a compound annual growth rate (CAGR) of 34.6%. The increasing adoption of AI-driven imaging solutions is expected to significantly shape the future of radiology practices in the region.

About Lunit

Founded in 2013, Lunit is on a mission to combat cancer through innovative AI technologies. The company specializes in medical image analytics and biomarker analysis, ensuring precise diagnoses and tailored therapies for cancer patients. The FDA-approved Lunit INSIGHT suite is currently utilized in over 4,800 medical institutions across more than 55 countries, with clinical studies published in renowned journals and presented at global conferences, demonstrating the effectiveness of their AI solutions in enhancing cancer care.

For more information about Lunit and its initiatives, visit lunit.io.